1. IndiaInfoline
  2. Search
Displaying Results for "lupin"
Showing Results 1 - 19 of 1544

Lupin closes down ~3.69%; ties up with Merck Serono

India Infoline News Service  | Mumbai September 16, 2014 16:41 IST

Lupin had hit a high of Rs. 1,442 and a low of Rs. 1,351 on BSE

Lupin ties up with Merck Serono; stock down ~3%

India Infoline News Service  | Mumbai September 16, 2014 14:53 IST

Lupin will support Merck Serono in the implementation of the company's General Medicines portfolio expansion initiative in emerging markets

Lupin hits day's high

India Infoline News Service  | Mumbai September 15, 2014 15:05 IST

Lupin opened at Rs. 1,359 and hit a high of Rs. 1395 on BSE

Lupin up ~2%; Co may sign deal with Merck Serono

India Infoline News Service  | Mumbai September 15, 2014 13:42 IST

Lupin opened at Rs. 1,359 and hit a high of Rs. 1386 on BSE

Lupin enters into distribution agreement with Salix Pharma

India Infoline News Service  | Mumbai September 12, 2014 16:07 IST

Lupin will promote the Salix products through its own sales force in Canada.

Lupin in deal with Salix Pharma...stock up 2%

India Infoline News Service  | Mumbai September 12, 2014 15:20 IST

The stock has hit a high of Rs1359 and a low of Rs1307.

Lupin in deal with Salix Pharma...stock up 2%

India Infoline News Service  | Mumbai September 12, 2014 15:20 IST

The stock has hit a high of Rs1359 and a low of Rs1307.

Lupin Limited - ESOPs/ESOS/ESPS

capital market  | Mumbai August 07, 2014 00:00 IST

Lupin Limited has informed the Exchange that the Company has granted 40200 options to the employees of its Subsidiary Companies, under Lupin Subsidiary Companies Employees Stock Option Plan 2011 on August 5, 2014, at the exercise price of Rs.1177.60.

Lupin launches Basugine

India Infoline News Service  | Mumbai August 06, 2014 15:51 IST

Lupin announced a strategic distribution agreement with LG Life Sciences to launch Insulin Glargine under the brand name Basugine.

Lupin to launch Basugine in India

capital market  | Mumbai August 06, 2014 15:47 IST

Enters into strategic distribution agreement with LG Life Sciences (South Korea)

Lupin Limited - Press Release

capital market  | Mumbai August 06, 2014 00:00 IST

Lupin Limited has submitted to the Exchange a copy of Press Release dated August 6, 2014 titled Lupin launched Basugine.

Lupin to launch Basugine in India

capital market  | Mumbai August 06, 2014 00:00 IST

Lupin announced a strategic distribution agreement with LG Life Sciences (South Korea) to launch Insulin Glargine, a novel insulin analogue under the brand name Basugine. According to the agreement, Lupin would be responsible for marketing and sales of Basugine in India.

Lupin (Q1 FY15)

India Infoline News Service  | Mumbai August 04, 2014 15:31 IST

Adjusted for Rs220mn above EBIDTA line forex item, absolute EBIDTA at Rs10.9bn was still a large beat on our estimate of Rs8.9bn driven by ~950bps yoy jump in margins to 33.4%.

Lupin

capital market  | Mumbai August 01, 2014 11:42 IST

Strong show

Lupin Limited - News Clarification

capital market  | Mumbai August 01, 2014 00:00 IST

The Exchange had sought clarification from Lupin Limited with respect to a news item captioned Debt - free Lupin is Ready for Big Acquisition : CEO. The Company has clarified that1) Comments on the news article: Ms. Vinita Gupta's comments about the Company being debt-free were based on the unaudited financial results for the quarter ended June 30, 2014, which were taken on record by the Board of Directors of Lupin Ltd. at its meeting held on July 30, 2014, conveyed to the Stock Exchanges and published in the newspapers. We wish to state that numbers quoted by Ms. Vinita in the news item forms part of the Press Release which was sent to the Stock Exchanges along with the said results.2) Material impact of the news article on the Company: In its day-to-day operations, the Company actively explores opportunities for organic and inorganic growth including overseas acquisitions. The Company shall promptly inform the Exchanges once an acquisition i

Lupin hits record high after strong Q1 results

capital market  | Mumbai July 30, 2014 14:48 IST

Lupin rose 5.18% to Rs 1,176.70 at 14:48 IST on BSE after the company announced strong Q1 June 2014 results during trading hours today, 30 July 2014.

Lupin stock surges 5% post Q1 results

India Infoline News Service  | Mumbai July 30, 2014 14:30 IST

Total Income has increased from Rs. 25771.10 mn for the quarter ended June 30, 2013 to Rs. 33697.30 mn for the quarter ended June 30, 2014.

Lupin jumps after Q1 results

capital market  | Mumbai July 30, 2014 14:23 IST

Lupin rose 4.84% to Rs 1,172.80 at 14:22 IST on BSE after consolidated net profit rose 55.77% to Rs 624.74 crore on 30.76% increase in total income to Rs 3369.73 crore in Q1 June 2014 over Q1 June 2013.

Lupin gains after strong Q1 results

capital market  | Mumbai July 30, 2014 14:22 IST

Lupin gains after strong Q1 results

Back to Top

 

 
 
 
Recent Reports
News